TNF and rheumatoid arthritis: Although numerous studies, including in animals, have addressed the causes of sex disparities in autoimmune diseases, including RA [27], to date, no studies have addressed the mechanisms mediating how immunotherapies, including TNF inhibitors, have greater efficacy and fewer reported adverse reactions in males compared with females.